Continue
By using our website you accept our cookies policy.Find out more

Synthetic Biology

Partnering the UK’s growing synthetic biology industry with industrial collaborators, research-base expertise, investment opportunities and funders

Partnering the UK’s growing synthetic biology industry with industrial collaborators, research-base expertise, investment opportunities and funders

The Synthetic Biology Special Interest Group (SynBio SIG) helps to partner the UK’s growing synthetic biology industry with industrial collaborators, research-base expertise, investment opportunities and funders.

Funded by Innovate UK and BBSRC, the SynBio SIG is coordinated by the Knowledge Transfer Network to bring together the UK’s best and brightest biotechnologists and help them form new, productive partnerships and collaborations.

We are working with the UK Synthetic Biology Leadership Council (SBLC) in the implementation of Biodesign for the Bioeconomy, the UK Synthetic Biology Strategic Plan 2016, to establish an internationally competitive synthetic biology industry in the UK.

You may also find KTN’s Synthetic Biology Landscape Map useful – an overview of synthetic biology companies, research capabilities, funding, support and more.

For more detail on the group please contact.

Dana Heldt – KTM Synthetic Biology

Join the Synthetic Biology Special Interest Group here

You can also keep up up to date with the Synthetic Biology Special Interest Group by following us on Twitter and joining our LinkedIn group.

News
Animal, in vitro and computational models for preclinical analysis of cell-based cancer therapies workshop
The NC3Rs and the Cell and Gene Therapy Catapult are hosting a workshop on Monday 19th November in Central London.
The challenges and opportunities of protein and peptide commercialisation
KTN's Knowledge Transfer Manager for Synthetic Biology, Dana Heldt explores 'directed evolution' and profiles some UK companies working in this space.
Perspectives
Downstream process development of next generation challenging proteins
The Knowledge Transfer Network, GlaxoSmithKline (GSK) and GE Healthcare Life Sciences (GE), organised an event on downstream processing.
Content types: All
All
Articles
Events
People
Funding opportunities
Programmes
Pages